Adaptive Designs in Clinical Trials
Hear through case studies how all sizes of pharmaceutical companies have successfully implemented trials incorporating adaptive designs. This conference is the only in Europe that focuses on adaptive designs specifically, providing delegates with updates on recent developments in enrichment design, dose response modelling, computer simulation, internal and external regulatory expectations and new data on evaluating adaptive dose ranging studies.
Adaptive Designs in Clinical Trials 2014 aims to show you how you can quickly and accurately implement an adaptive design clinical trial for your drug development – from init...
Source: Nature Network London - Upcoming Events - November 26, 2013 Category: Science Source Type: events
Asthma and Copd
The global market for Asthma and COPD drugs is set to reach $47bn in 2017. There is a growing demand for the next generation of inhaled combination products and novel therapeutics.
Asthma and COPD 2014 will enable delegates to gain valuable insights into the latest ground-breaking advances in the respiratory drug market. It will focus on the challenges and strategies to enhance patient outcomes, providing extensive knowledge from the key leading industry and academic experts.
Business Benefits for 2014:
• New for 2014 – Four round table discussions to enhance networking capabilities between delegates and sponsors
...
Source: Nature Network London - Upcoming Events - November 21, 2013 Category: Science Source Type: events
Paediatric Clinical Trials 2014
Building on the success of our previous events, SMi is proud to present the 8th instalment in the popular conference series; Paediatric Clinical Trials , taking place on 31st March and 1st April 2014, London UK.
This event will bring together key opinion leaders to provide attendees with an in depth look into current advances in paediatric clinical trials and drug development with a complete view of the paediatric market.
Presentations will focus on regulatory requirements, challenges in clinical trials design, formulation development, extrapolation form the adult population plus much more.
Why Attend this Event in 2014:
â...
Source: Nature Network London - Upcoming Events - November 19, 2013 Category: Science Source Type: events
Oncology Imaging for Drug Development
SMi’s 10th annual Oncology Imaging for Drug Development conference will provide attendees with a comprehensive insight into the industry and its future. We will be considering the current landscape of personalised imaging within the field of oncology, as research suggests healthcare that is inherently more ‘personal’ is the way forward. In addition, this year’s event will explore current and future legislation and its impact on imaging. The use of imaging in clinical trials will also be examined and discussed together with the use of novel biomarkers.
Event highlights include:
• Examine the challenges of mul...
Source: Nature Network London - Upcoming Events - November 15, 2013 Category: Science Source Type: events
Introduction to Pharmacokinetics for the Non-Specialist
The vast majority of failures at late stage clinical trials and post marketing are due to druginteractions.
Pharmacokinetics (PK) and pharmacodynamics (PD) play a key role in drug development, and a good understanding of the implications of PK/PD data is crucial when designing clinical trails or preparing a drug submission dossier.
Throughout the pharmaceutical and biotech industries, there is a general lack of understanding of these crucial areas of knowledge.
With PK data playing an ever more vital role in the development process, this lack of knowledge needs to be addressed, to increase real communication between depart...
Source: Nature Network London - Upcoming Events - October 25, 2013 Category: Science Source Type: events
mHealth for Behaviour Change
The SMi Group, in association with3G Doctor, proudly present a masterclass on mHealth for behaviour change
mHealth is a rapidly emerging and lucrative field with opportunities coming to the fore, within mainstream healthcare. The pharmaceutical industry presents excellent partnership opportunities with mHealth influencing and revolutionizing patient care, business processes, and clinical trials. mHealth technologies may also support day to day business operations of Pharma, and with more and more mHealth technologies being adopted by Pharma, the future of mHealth is very promising.
This comprehensive masterclass will use s...
Source: Nature Network London - Upcoming Events - September 18, 2013 Category: Science Source Type: events
ESC Congress 2014
Start event date:
30/08/2014
End event date:
03/09/2014
City:
Barcelona
Country:
Spain
Summary:
The world’s largest and most influential cardiovascular event contributing to global awareness of the latest clinical trials and breakthrough discoveries.
Ebac Accredited:
no
Topics: (Source: ESC Congress and Events)
Source: ESC Congress and Events - August 27, 2013 Category: Cardiology Source Type: events
Pharmaceutical Law Academy 2013
Summary
Pharmaceutical Law Academy: A Unique, Residential, Pharmaceutical Law Grounding and High-level, Comprehensive Update Set in Beautiful Cambridge University
Description
The case studies and debate at the end of each of the Advanced Days are designed to consolidate all you’ve learned throughout the conference day. In a highly practical example, followed by a panel debate on the issues the day highlights, this succesfi; unique formula will give you insights into the application of the unmissable case law updates into your everyday role.
Day 1 – Fundamentals Day
A superb introduction to the full range of Pharmac...
Source: Nature Network London - Upcoming Events - July 9, 2013 Category: Science Source Type: events
Epigenetic Innovations
From 9:00 am to 4:10 pm
Summary:
Clinically-approved epigenetic therapies are currently effective in only one area: leukaemia. But this belies their true potential.
Description:
Treatments in development are rapidly expanding across disciplinary boundaries into solid tumours, inflammatory, neurological, metabolic and rare diseases.
Following extensive discussions with senior industry and academic experts, Pharma IQ’s Epigenetic Innovations summit will focus on fundamental mechanisms, chemical targets and therapies unrestricted by therapeutic area. Expertise in bioinformatics, sequencing, medicinal chemistry and clini...
Source: Nature Network London - Upcoming Events - July 1, 2013 Category: Science Source Type: events
Clinical Trial Supply
Summary:
Cutting Costs, Introducing Flexibility and Streamlining your Global Clinical Trial Supply Chain.
Description:
Clinical development continues to be the most expensive, time consuming aspect of getting a drug to market and ensuring the safe, accurate supply of clinical trial products to project sites provides yet more challenges to overcome in the process.
Top 5 Reasons to Attend
1. Hear from 20+ leading industry experts, network and interact with 150+ peers and community leaders
2. Find out what your peers are really thinking in our most interactive, discussion focused event yet!
3. Latest developments in IxRS tech...
Source: Nature Network London - Upcoming Events - June 28, 2013 Category: Science Source Type: events
Cosy Science presents: Repairing the brain with stem cells with Prof Jack Price
The first clinical trial of stem cells for a neurodegenerative disease in the UK is now underway. Does this mean that a new era of regenerative medicine for brain disorders is upon us? Could it also herald the advent of ‘human enhancement’ using stem cell technologies? Or is it possible that neuroscientists don’t really know what they are doing, and just got lucky?
Jack Price is Professor of Developmental Neurobiology at the Institute of Psychiatry, King’s College London, and is Head of the Institute’s Centre for the Cellular Basis of Behaviour. He is also a consultant for ReNeuron Ltd., a...
Source: Nature Network London - Upcoming Events - April 12, 2013 Category: Science Source Type: events
